000			01190cam a2200301 4500500
005			20250121110801.0
041			_afre
042			_adc
100	1	0	_aDelile, Jean-Michel _eauthor
245	0	0	_aCannabis and schizophrenia
260			_c2022.
500			_a90
520			_aIn the debate on regulating access to cannabis, the question of the links between cannabis and schizophrenia must be taken into account. The author proposes in this article a precise medical framework on the reality of this risk and on the identification of the vulnerabilities of target populations. It also invites a reflection on modulated approaches to prevention and harm reduction.
690			_aharm reduction
690			_aschizophrenia
690			_avulnerability factors
690			_acannabis
690			_astudy
690			_apsychosis
690			_aharm reduction
690			_aschizophrenia
690			_avulnerability factors
690			_acannabis
690			_astudy
690			_apsychosis
786	0		_nPsychotropes | 28 | 1 | 2022-08-12 | p. 135-142 | 1245-2092
856	4	1	_uhttps://shs.cairn.info/journal-psychotropes-2022-1-page-135?lang=en&redirect-ssocas=7080
999			_c538203 _d538203